Skip to main content
Premium Trial:

Request an Annual Quote

Geneart Gets Grant to Participate in HIV Vaccine Development

NEW YORK (GenomeWeb News) – Geneart said yesterday that the European Commission has awarded it€300,000 ($470,000) under its 7th Framework Program to participate in a project called "New HIV Vaccines Inducing Broadly Reactive Neutralizing Antibodies."
The Regensburg, Germany-based firm will create custom-designed gene sequences for HIV vaccine candidates being developed by the project, which is coordinated by Sanofi Pasteur, the vaccines division of Sanofi-Aventis. The consortium behind the project includes 15 research groups that have received a total contribution of nearly €12 million from the European Union.
Geneart said that its technology would be used to optimize gene sequences for highest yields in the selected production system. In addition, it said it would “systemically analyze the influence of different sequence motives — specific successions of bases in a given gene — on production rates in the laboratory.”

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.